18/06/2024  22:10:00 Chg. +0.10 Volume Bid00:11:36 Demandez à00:11:36 Capitalisation boursière Dividende Y. Rapport P/E
64.96USD +0.15% 181,271
Chiffrre d'affaires: 6.1 Mio.
59.50Bid taille: 100 67.94Ask la taille: 100 3.24 Mrd.USD - -

Description de l'entreprise

Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
 

Conseil d'administration & Conseil de surveillance

PDG
Ron Lombardi
Conseil d'administration
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool
Conseil de surveillance
Ron Lombardi, Christopher J. Coughlin, Dawn M. Zier, Dr. Celeste A. Clark, Dr. Gary E. Costley, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins
 

Données de l'entreprise

Nom: Prestige Consumer Healthcare, Inc.
Adresse: 660 White Plains Road,Tarrytown, New York 10591, USA
Téléphone: +1-914-524-6800
Fax: -
Courriel: Irinquiries@prestigebrands.com
Internet: www.prestigebrandsinc.com/
Industrie: Consumer Goods
Secteur: Cosmetics
Sous-secteur: Cosmetics
Fin de l'exercice financier: 31/03
Flotte libre: 69.88%
IPO date: -

Relations avec les investisseurs

Nom: Phil Terpolilli
Téléphone IR: +1-914-524-6819
IR-Fax: -
E-mail IR: -

Principaux actionnaires

Freefloat
 
69.88%
BlackRock, Inc.
 
12.50%
The Vanguard Group
 
10.72%
Dimensional Fund Advisors LP
 
6.90%